MedTrace Logo

Ability to Awaken in Nonmonosymptomatic Enuresis

NCT02845648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2016-07-28

No results posted yet for this study

Summary

To evaluate the effect of controlling lower urinary tract symptoms (LUTS) with anticholinergics on improving the ability to awaken (AA) in children with nonmonosymptomatic enuresis and evaluate the potential implication of improved AA for treatment response prediction.

Conditions

  • Enuresis, Nocturnal, 2 (Disorder)

Interventions

DRUG

anticholinergic

Initial anticholinergic therapy to all patients

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kwanjin PArk, Pf. · Seoul National University Hospital

Eligibility

Min Age
5 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2015-07-31
Completion
2015-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02845648 on ClinicalTrials.gov